• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

客座编辑专刊:肿瘤微环境中的表观遗传学。

Guest Edited Collection: Epigenetics within the tumor microenvironment.

机构信息

Dermatology Institute and Translational Research Institute, Academic Health System, Hamad Medical Corporation, Doha, 3050, Qatar.

出版信息

Sci Rep. 2022 Sep 5;12(1):15089. doi: 10.1038/s41598-022-19042-6.

DOI:10.1038/s41598-022-19042-6
PMID:36064963
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9445032/
Abstract

The tumor microenvironment (TME) comprises of components that exist within the immediate vicinity of tumor cells, including fibroblasts, immune cells, the extracellular matrix, and more. Significant advances have been made in recent years in our understanding of the components of TME and their mutual interactions. Part of the focus of this research has been on epigenetic events, which are increasingly being recognized for their importance in gene regulation and cancer progression. The Collection represents the gradual growth in our understanding of the overall process of how cancer progresses, along with the factors that play a decisive role in this progression. It features studies conducted on models representing many different cancers, and includes mechanistic reports conducted using appropriate in vitro models, studies that analyzed human cancer patients-derived specimens, clinical trials and, additionally, studies involving bioinformatics, metabolomics, chemical libraries screening, next-generation sequencing, and single-cell analysis approaches.

摘要

肿瘤微环境(TME)包括存在于肿瘤细胞附近的各种成分,如成纤维细胞、免疫细胞、细胞外基质等。近年来,我们对 TME 的组成及其相互作用有了更深入的了解,并取得了重大进展。研究的重点之一是表观遗传事件,这些事件因其在基因调控和癌症进展中的重要性而日益受到重视。该专题代表了我们对癌症进展整体过程以及在这一过程中起决定性作用的因素的理解逐渐加深。它收录了在代表多种不同癌症的模型上进行的研究,包括使用适当的体外模型进行的机制研究、对源自人类癌症患者的标本进行的分析研究、临床试验,此外还包括涉及生物信息学、代谢组学、化学文库筛选、下一代测序和单细胞分析方法的研究。

相似文献

1
Guest Edited Collection: Epigenetics within the tumor microenvironment.客座编辑专刊:肿瘤微环境中的表观遗传学。
Sci Rep. 2022 Sep 5;12(1):15089. doi: 10.1038/s41598-022-19042-6.
2
Single cell cancer epigenetics.单细胞癌症表观遗传学。
Trends Cancer. 2022 Oct;8(10):820-838. doi: 10.1016/j.trecan.2022.06.005. Epub 2022 Jul 9.
3
Roadmap on plasticity and epigenetics in cancer.癌症中的可塑性和表观遗传学路线图。
Phys Biol. 2022 Apr 18;19(3). doi: 10.1088/1478-3975/ac4ee2.
4
Understanding the Crosstalk Between Epigenetics and Immunometabolism to Combat Cancer.了解表观遗传学和免疫代谢之间的串扰以对抗癌症。
Subcell Biochem. 2022;100:581-616. doi: 10.1007/978-3-031-07634-3_18.
5
Metabolic Ink Lactate Modulates Epigenomic Landscape: A Concerted Role of Pro-tumor Microenvironment and Macroenvironment During Carcinogenesis.代谢墨水乳酸调节表观基因组景观:在癌变过程中促肿瘤微环境和宏环境的协同作用。
Curr Mol Med. 2021;21(3):177-181. doi: 10.2174/1566524020666200521075252.
6
Metabolic recoding of epigenetics in cancer.癌症中表观遗传学的代谢重编程。
Cancer Commun (Lond). 2018 May 21;38(1):25. doi: 10.1186/s40880-018-0302-3.
7
Epigenomic interplay in tumor heterogeneity: Potential of epidrugs as adjunct therapy.肿瘤异质性中的表观基因组相互作用:表皮生长因子受体酪氨酸激酶抑制剂作为辅助治疗的潜力。
Cytokine. 2022 Sep;157:155967. doi: 10.1016/j.cyto.2022.155967. Epub 2022 Jul 26.
8
Intratumor heterogeneity: origins, clinical significance and optimal strategies for cancer treatment.肿瘤内异质性:起源、临床意义及癌症治疗的最佳策略
Future Oncol. 2015;11(4):561-4. doi: 10.2217/fon.14.296.
9
Methylation of immune synapse genes modulates tumor immunogenicity.免疫突触基因的甲基化调节肿瘤免疫原性。
J Clin Invest. 2020 Feb 3;130(2):974-980. doi: 10.1172/JCI131234.
10
Understanding the epigenetic interface between the cell and the genome: a supplemental issue of DNA and cell biology on epigenetics.理解细胞与基因组之间的表观遗传界面:《DNA与细胞生物学》表观遗传学增刊
DNA Cell Biol. 2012 Oct;31 Suppl 1:S1. doi: 10.1089/dna.2012.2519.

引用本文的文献

1
VIM-AS1, which is regulated by CpG methylation, cooperates with IGF2BP1 to inhibit tumor aggressiveness via EPHA3 degradation in hepatocellular carcinoma.VIM-AS1受CpG甲基化调控,在肝细胞癌中通过EPHA3降解与IGF2BP1协同作用以抑制肿瘤侵袭性。
Exp Mol Med. 2024 Dec;56(12):2617-2630. doi: 10.1038/s12276-024-01352-6. Epub 2024 Dec 2.
2
Corruptive Reprograming of Macrophages into Tumor-Associated Macrophages: The Transcriptional, Epigenetic and Metabolic Basis.巨噬细胞向肿瘤相关巨噬细胞的致瘤性重编程:转录、表观遗传和代谢基础
Cancers (Basel). 2023 Aug 28;15(17):4291. doi: 10.3390/cancers15174291.

本文引用的文献

1
Prognostic impact of miR-34b/c DNA methylation, gene expression, and promoter polymorphism in HPV-negative oral squamous cell carcinomas.miR-34b/c DNA 甲基化、基因表达和启动子多态性对 HPV 阴性口腔鳞状细胞癌预后的影响。
Sci Rep. 2022 Jan 25;12(1):1296. doi: 10.1038/s41598-022-05399-1.
2
Epigenetic regulation of immunosuppressive tumor-associated macrophages through dysregulated microRNAs.通过失调的微小RNA对免疫抑制性肿瘤相关巨噬细胞进行表观遗传调控。
Semin Cell Dev Biol. 2022 Apr;124:26-33. doi: 10.1016/j.semcdb.2021.09.001. Epub 2021 Sep 21.
3
Structural insights of human N-acetyltransferase 10 and identification of its potential novel inhibitors.人类N-乙酰转移酶10的结构见解及其潜在新型抑制剂的鉴定。
Sci Rep. 2021 Mar 15;11(1):6051. doi: 10.1038/s41598-021-84908-0.
4
Potentiality of multiple modalities for single-cell analyses to evaluate the tumor microenvironment in clinical specimens.多种模式在单细胞分析中评估临床标本肿瘤微环境的潜力。
Sci Rep. 2021 Jan 11;11(1):341. doi: 10.1038/s41598-020-79385-w.
5
M1 Macrophage and M1/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancer.基于转录组特征定义的 M1 巨噬细胞和 M1/M2 比值仅部分类似于乳腺癌的传统临床特征。
Sci Rep. 2020 Oct 6;10(1):16554. doi: 10.1038/s41598-020-73624-w.
6
A multiple drug loaded, functionalized pH-sensitive nanocarrier as therapeutic and epigenetic modulator for osteosarcoma.一种多药物负载、功能化的 pH 敏感纳米载体,作为骨肉瘤的治疗和表观遗传调节剂。
Sci Rep. 2020 Sep 23;10(1):15497. doi: 10.1038/s41598-020-72552-z.
7
Novel role of lncRNA CHRF in cisplatin resistance of ovarian cancer is mediated by miR-10b induced EMT and STAT3 signaling.长链非编码 RNA CHRF 在顺铂耐药卵巢癌中的新作用是通过 miR-10b 诱导的 EMT 和 STAT3 信号传导介导的。
Sci Rep. 2020 Sep 8;10(1):14768. doi: 10.1038/s41598-020-71153-0.
8
LncRNA MALAT1 facilitates lung metastasis of osteosarcomas through miR-202 sponging.长链非编码 RNA MALAT1 通过海绵吸附 miR-202 促进骨肉瘤的肺转移。
Sci Rep. 2020 Jul 29;10(1):12757. doi: 10.1038/s41598-020-69574-y.
9
Let-7c regulated epithelial-mesenchymal transition leads to osimertinib resistance in NSCLC cells with EGFR T790M mutations.Let-7c 调控的上皮-间充质转化导致 EGFR T790M 突变的 NSCLC 细胞对奥希替尼耐药。
Sci Rep. 2020 Jul 8;10(1):11236. doi: 10.1038/s41598-020-67908-4.
10
Epigenetic profiling demarcates molecular subtypes of muscle-invasive bladder cancer.表观遗传学分析标记肌肉浸润性膀胱癌的分子亚型。
Sci Rep. 2020 Jul 2;10(1):10952. doi: 10.1038/s41598-020-67850-5.